Insilico CEO explains how AI-powered drug discovery significantly shortens approval timelines

Alex Zhavaronkov, the Founder, CEO and CBO of Insilico Medicine, joins Squawk Box Asia to discuss the usage of AI in the pharmaceutical industry, and the company's business strategy and outlook.